0002001011-23-000003.txt : 20231206
0002001011-23-000003.hdr.sgml : 20231206
20231206152713
ACCESSION NUMBER: 0002001011-23-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231205
FILED AS OF DATE: 20231206
DATE AS OF CHANGE: 20231206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Korenberg Matthew E
CENTRAL INDEX KEY: 0001649903
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 231469389
MAIL ADDRESS:
STREET 1: 11119 NORTH TORREY PINES ROAD
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2023-12-05
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001649903
Korenberg Matthew E
3911 SORRENTO VALLEY, SUITE 110
SAN DIEGO
CA
92121
0
1
0
0
PRESIDENT & CHIEF OPERATING
0
Common Stock
2023-12-05
4
F
0
1984
59.61
D
97140
D
Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.
By: /s/ Andrew Reardon, Attorney-in-Fact For: Octavio Espinoza
2023-12-06